Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia

Endocrine. 2012 Feb;41(1):160-1. doi: 10.1007/s12020-011-9549-z.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Glands / pathology*
  • Adrenal Glands / physiopathology
  • Adrenocorticotropic Hormone / physiology*
  • Aged
  • Cushing Syndrome / drug therapy*
  • Cushing Syndrome / physiopathology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Humans
  • Hyperplasia
  • Metyrapone / adverse effects*
  • Metyrapone / therapeutic use*
  • Steroid 11-beta-Hydroxylase / antagonists & inhibitors
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Adrenocorticotropic Hormone
  • Steroid 11-beta-Hydroxylase
  • Metyrapone